Related Experiment Video
Updated: Jun 3, 2026

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
Engineering an Escherichia coli - Saccharomyces cerevisiae consortium for 2-phenylethyl glucosinolate biosynthesis
William Thomas Wajn1, Michal Poborsky1, Christoph Crocoll1
1DynaMo Center, Department of Plant and Environmental Sciences, University of Copenhagen, Frederiksberg, Denmark.
This study presents the first microbial biosynthesis of 2-phenylethyl glucosinolate (2PE) using engineered E. coli and S. cerevisiae. This breakthrough enables the production of complex glucosinolates from amino acids, advancing nutraceutical and agricultural biotechnology.
Area of Science:
- Biotechnology
- Metabolic Engineering
- Synthetic Biology
Background:
- Glucosinolates are vital sulfur-rich plant metabolites with significant nutraceutical and agricultural applications.
- Microbial production of complex glucosinolates is hindered by challenges in expressing key biosynthetic enzymes, particularly those involved in chain elongation of amino acids.
Purpose of the Study:
- To establish the first microbial biosynthesis pathway for 2-phenylethyl glucosinolate (2PE), a complex glucosinolate derived from chain-elongated amino acids.
- To develop a modular engineering strategy combining Escherichia coli and Saccharomyces cerevisiae for efficient production.
Main Methods:
- Utilized a modular engineering approach, with a bacterial module for amino acid side chain elongation (phenylalanine to homophenylalanine) and a yeast module for core glucosinolate structure synthesis.
- Optimized individual modules by screening brassicaceous enzyme variants (CYP79F, MAM, BCAT) and enhanced co-factor availability (PAPS) through sulfate feeding.
- Implemented co-culture strategies, optimized carbon sources, and autoinduction for enhanced 2PE titers.
Main Results:
- Successfully achieved functional expression of an iron-sulfur cluster enzyme in E. coli for amino acid elongation.
- Identified superior enzyme variants and optimized PAPS co-factor availability, leading to a 10-fold increase in 2PE titers and alleviating the desulfo-2-phenylethyl glucosinolate (ds-2PE) bottleneck.
- Demonstrated the first microbial biosynthesis of 2PE from phenylalanine by combining the engineered bacterial and yeast modules.
Conclusions:
- Established a robust platform for the microbial production of complex glucosinolates derived from chain-elongated amino acids.
- Pathway modularization and co-culture engineering are effective strategies for overcoming limitations in expressing complex biosynthetic pathways.
- This work paves the way for biotechnological applications of glucosinolates in nutraceuticals and agriculture.
Related Concept Videos
Bioreactor Controls-III
Production of Pharmaceuticals
Production of Alcohol

